Table 2—

Individual data in eight pulmonary veno-occlusive (PVOD) disease patients

PVOD patient No.SexAge yrsNYHA baseline6-MWD mmPAP mmHgPAWP mmHgTPR IU·m−2CI L·min−1·m−2Pa,O2 mmHgDL,CO/VA% predAlveolar cell·mL−1Golde scoreCL ground-glass opacitiesSeptal linesAdenopathy
1F30IV0713431.61000000200111
2F50III105695591.1743014200022110
3M70III905910203483618500039011
4M52III22558212.75930100000086001
5F48III390607242.5455127900032011
6M65II360624411.546.5206000234011
7M72II2804611212.16620600033011
8M25III280526212.467.5402640000011
Mean±sd5 M/3 F52±17216±13859±87±331±152.1±0.758±1137±9410250±36650081±882/87/87/8
  • NYHA: New York Heart Association; 6-MWD: 6-min walk distance; mPAP: mean pulmonary artery pressure; PAWP: pulmonary arterial wedge pressure; TPR: total pulmonary resistance; CI: cardiac index; Pa,O2: arterial oxygen pressure; DL,CO/VA % pred: carbon monoxide diffusing capacity/alveolar volume percentage predicted; CL: centrilobular; F: female; M: male. 1 mmHg = 0.133 kPa.